Hints and tips:
Related Special Reports
...Gareth Powell, head of healthcare at specialist fund manager Polar Capital, said mRNA was following previous platforms such as antibodies, in which investors would get excited about developers initially...
...SRT transactions have picked up, more than doubling globally to €200bn in the two years to 2022, according to data from S&P Global....
...to c.$1.2bn....
...Some would probably argue that more information is not the same as better information . . . but c’mon....
...At the same time, the alliance between Invesco, the three other lenders and Robertshaw fully disintegrated. Invesco bought up a majority stake across two Robertshaw loan tranches....
...The Hinkley Point C project is likely to exceed the revised £32.7bn estimate EDF put on it earlier this year after its Chinese partner CGN halted payments to cover mounting cost overruns....
...“In late April and May for newly diagnosed ovarian cancer patients I had to make drug substitutions because we did not have the sort of first-choice drugs available,” said Jennifer Rubatt, an oncology specialist...
...In contrast, the multi-manager model relies on specialist traders, overseen by sophisticated risk management technology, and a ruthless approach to hiring and firing by their paymasters....
...Higher risks make this a market for specialists. The perimeter of the financial junkyard is defined by a rating of BB+ from Fitch and S&P, and Ba1 from Moody’s....
...It is not a stretch for Sanofi, with a net debt-to-ebitda ratio of 0.6 according to S&P Capital IQ....
...Big global equity trusts F&C (FCIT), Brunner (BUT) and Alliance Trust (ATST) have all outperformed the MSCI World index in the past year, thanks to their portfolios having less exposure to underperforming...
...The company, which was founded by specialist venture capital firm Monograph Capital at the start of last year, has already bought a Potters Bar site from Cancer Research UK, the German manufacturing business...
...After assembling a team of specialists for a complicated job, a contractor falls asleep on a plane....
...Some good news UK regulators have authorised the use of a drug that could help prevent breast cancer in women....
...He will travel from Seoul to Tokyo on Monday to reinforce the transatlantic security alliance’s ties with its key partners in Asia....
...Business coach Julie Stokes has just helped launch a new executive retreat at Goodwood with gut-health specialist and psychotherapist Stephanie Moore....
...It achieved records in four of its five business units last year, with its fixed income strategy making 32.6 per cent, ahead of many specialist macro funds....
...In 2014, Oxford-based Circassia Pharmaceuticals, an allergy specialist, launched a £581mn initial public offering, a record at the time for a London-listed biotech....
...In October J&J put into bankruptcy an affiliate with liabilities for thousands of lawsuits tying talc-based products to cancer. Recent demergers have been patchy....
...By June next year, S&P Global is predicting the US default rate will rise to 4.5 per cent, up from 1.7 per cent at the start of 2023....
...Alliance Pharma, M&C Saatchi and YouGov all fall in this zone. But it’s not only about individual companies....
...We expect the same technology, deployed by the likes of Moderna and Merck, to produce vaccines against some forms of cancer. Science is finally starting to cut the Big C down to size....
...The Canadian Association of Petroleum Producers, which represents the upstream oil and gas sector, yesterday said the country’s industry will spend C$40bn ($29bn) this year....
...opened Shinta Mani Wild, his (way) out-there camp in the remote South Cardamom National Forest, the remit shifted to focus on wildlife: it funds a team of armed rangers overseen by the local NGO Wildlife Alliance...
...It follows Lauren’s co-founding of the Nina Hyde Centre for Breast Cancer Research in 1989, among other causes geared toward cancer research and treatment throughout his career....
International Edition